NewLimit, a health company founded by Coinbase's founder, has completed a $130 million Series B financing.

robot
Abstract generation in progress

Foresight News reports that, according to Fortune magazine, NewLimit, an anti-aging startup founded by Coinbase founder Brian Armstrong, has completed a $130 million Series B financing round, led by Kleiner Perkins, with participation from Khosla Ventures and Founders Fund. Brian Armstrong stated that NewLimit's research is based on a relatively new scientific field—epigenetic reprogramming, which can manipulate cells to restore them to a younger or healthier state.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)